Trials / Conditions / Lymphomas Non-Hodgkin's B-Cell

Lymphomas Non-Hodgkin's B-Cell

8 registered clinical trials studyying Lymphomas Non-Hodgkin's B-Cell — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Investigate Safety of INT2104 Infusions in Participants Aged 18 Years of Age and Older Who Have B-c NCT06539338	Kite, A Gilead Company	Phase 1
Recruiting	T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) NCT06343311	Estrella Biopharma, Inc.	Phase 1 / Phase 2
Not Yet Recruiting	Obinutuzumab in Chinese Real-world Patients With iNHL NCT05968001	Affiliated Hospital of Nantong University	—
Active Not Recruiting	ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy) NCT04049513	Malaghan Institute of Medical Research	Phase 1
Terminated	Study of ET190L1 ARTEMIS™ T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's Lymphoma NCT03379493	Eureka Therapeutics Inc.	Phase 1
Recruiting	Long-term Follow-up Study of Patients Receiving CAR-T Cells NCT03375619	Medical College of Wisconsin	—
Active Not Recruiting	Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CH NCT03244176	Austin Health	EARLY_Phase 1
Completed	CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma NCT03029338	Institute of Hematology & Blood Diseases Hospital, China	Phase 1